Literature DB >> 21475175

Fix the antibiotics pipeline.

Matthew A Cooper1, David Shlaes.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21475175     DOI: 10.1038/472032a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Stoking the antibiotic pipeline.

Authors:  Chantal M Morel; Elias Mossialos
Journal:  BMJ       Date:  2010-05-18
  1 in total
  130 in total

1.  A community-based approach to new antibiotic discovery.

Authors:  Matthew A Cooper
Journal:  Nat Rev Drug Discov       Date:  2015-08-07       Impact factor: 84.694

Review 2.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

Review 3.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

4.  The FDA reboot of antibiotic development.

Authors:  David M Shlaes; Dan Sahm; Carol Opiela; Brad Spellberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

5.  Identifying producers of antibacterial compounds by screening for antibiotic resistance.

Authors:  Maulik N Thaker; Wenliang Wang; Peter Spanogiannopoulos; Nicholas Waglechner; Andrew M King; Ricardo Medina; Gerard D Wright
Journal:  Nat Biotechnol       Date:  2013-09-22       Impact factor: 54.908

Review 6.  Antibiotics in the clinical pipeline at the end of 2015.

Authors:  Mark S Butler; Mark At Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

Review 7.  Antimicrobial peptides: new drugs for bad bugs?

Authors:  Jonathan D Steckbeck; Berthony Deslouches; Ronald C Montelaro
Journal:  Expert Opin Biol Ther       Date:  2013-11-11       Impact factor: 4.388

8.  Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.

Authors:  Lizah T van der Aart; Nicole Lemmens; Willem J van Wamel; Gilles P van Wezel
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.

Authors:  Tao Xiao; Ke Liu; Robert W Huigens
Journal:  Bioorg Med Chem Lett       Date:  2020-08-27       Impact factor: 2.823

Review 10.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.